Physician profile
Thomas C Pitman
NPI 1902807878
$155,924.65
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $131 · 2021: $15K · 2022: $75K · 2023: $66K · 2024: $30.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $13K · Food and Beverage: $1,590 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,000.00 |
| Travel and Lodging | $12,670.60 |
| Food and Beverage | $1,589.95 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $155,114.14 | 2021-2023 | Gelpoint V-Path |
| Medtronic, INC. | $293.84 | 2022-2023 | Interstim |
| Coloplast Corp | $205.39 | 2019-2020 | |
| Abbvie INC. | $39.59 | 2019 | |
| Coopersurgical, INC. | $38.40 | 2021 | |
| Daiichi Sankyo INC. | $35.54 | 2019-2021 | |
| Boston Scientific Corporation | $30.57 | 2024 | Wavewriter Alpha Prime 16 |
| Nuvasive, INC. | $23.33 | 2022 | |
| Hologic Sales and Service, LLC | $22.35 | 2022 | |
| Avanos Medical | $17.49 | 2019 | |
| Olympus America INC. | $14.83 | 2020 | |
| Shield Therapeutics INC | $14.25 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $14.04 | 2019 | |
| Astellas Pharma US INC | $13.23 | 2019 | |
| Amgen INC. | $12.37 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.24 | 2019 | |
| Lilly USA, LLC | $11.98 | 2019 | |
| Genentech USA, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Pitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.